Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Go back to Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics| (NASDAQ: AKTX) | Delayed: 9.96 -0.09 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.05 | 52 Week High | $19.75 | |||
| Open | $10.42 | 52 Week Low | $7.63 | |||
| Day High | $10.42 | P/E | N/A | |||
| Day Low | $9.50 | EPS | $0.00 | |||
| Volume | 16,231 | |||||
| (NASDAQ: AKTX) | Delayed: 9.96 -0.09 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.05 | 52 Week High | $19.75 | |||
| Open | $10.42 | 52 Week Low | $7.63 | |||
| Day High | $10.42 | P/E | N/A | |||
| Day Low | $9.50 | EPS | $0.00 | |||
| Volume | 16,231 | |||||

